Streetbeat News

Regulatory

TTOO

T2 Biosystems, Inc. (NASDAQ:TTOO) shares are trading higher after the FDA cleared the company's biothreat panel for commercial distribution. The stock is trading above its 50-day moving average on heavy trading volume, with over 166 million shares traded in the session. TTOO is currently one of the top trending tickers on Yahoo! Finance and Stocktwits.

Portfolio Pulse from Erica Kollmann

September 18, 2023 | 4:00 pm

GOOG

GOOGL

META

NVDA

The UK's Competition and Markets Authority (CMA) is outlining principles to deter tech corporations from monopolizing AI models like ChatGPT. The UK is also preparing to host a global AI safety summit featuring AI leaders from Alphabet Inc, Nvidia Corp, Meta Platforms Inc, OpenAI, Anthropic, and others. In the US, a tech summit led by Senate Majority Leader Chuck Schumer saw participation from the same tech CEOs, civil society leaders, and over 60 senators. The aim was to reach a consensus as the Senate considers AI industry legislation.

Portfolio Pulse from AJ Fabino

September 18, 2023 | 3:49 pm

USO

Saudi Arabia's Energy Minister has urged caution, stating that it is necessary to wait until real numbers are seen in market tightness before making any decisions. The statement comes amid rising oil prices and speculation about potential changes in production levels.

Portfolio Pulse from Benzinga Newsdesk

September 18, 2023 | 3:48 pm

TTOO

T2 Biosystems shares are trading higher after the FDA cleared the company's biothreat panel for commercial distribution.

Portfolio Pulse from Benzinga Newsdesk

September 18, 2023 | 3:42 pm

TTOO

T2 Biosystems has received FDA 510(k) decision of substantially equivalent for its T2 Biothreat Panel, a multiplex nucleic acid detection system for biothreat agents. This approval could potentially boost the company's market position and sales.

Portfolio Pulse from Benzinga Newsdesk

September 18, 2023 | 3:41 pm

Unity Software has issued an apology via Twitter regarding its recently announced runtime fee policy. The company has promised to provide an update in the coming days. This has led to a decrease in the company's share price.

Portfolio Pulse from Benzinga Newsdesk

September 18, 2023 | 3:35 pm

SPY

UNG

USO

The Biden Administration has expressed strong opposition to proposed legislation that would change the procedure for the approval of import and export of natural gas, according to a statement cited by Reuters.

Portfolio Pulse from Benzinga Newsdesk

September 18, 2023 | 3:35 pm

TSLA

USO

Elon Musk, CEO of Tesla, has refuted a Wall Street Journal report claiming that Tesla and Saudi Arabia are in early talks for an electric vehicle (EV) factory. The report was deemed false by Musk.

Portfolio Pulse from Benzinga Newsdesk

September 18, 2023 | 3:28 pm

BTCUSD

COIN

ETHUSD

FTTUSD

SOLUSD

Despite the token sale by bankrupt exchange FTX, the crypto market is expected to remain stable, according to Coinbase. FTX's holdings include $1.16 billion in Solana, $560 million in Bitcoin, and $192 million in Ether. FTX has been granted permission to liquidate and reinvest these assets to settle its debts. Coinbase has implemented protective measures capping initial sales at $50 million per week, which could increase to $100 million and potentially $200 million with approval from FTX's debtors.

Portfolio Pulse from Murtuza Merchant

September 18, 2023 | 3:27 pm

ACAD

Acadia Pharmaceuticals Inc. (NASDAQ:ACAD) announced that the U.S. Food and Drug Administration (FDA) has revised the Boxed Warning for its drug NUPLAZID, clarifying that it can be used to treat patients with Parkinson's disease-related hallucinations and delusions who also have dementia. The update is consistent with the current indication and includes no other changes.

Portfolio Pulse from Benzinga Newsdesk

September 18, 2023 | 3:20 pm